|
gptkbp:instance_of
|
gptkb:nuclear_weapons
|
|
gptkbp:application
|
surgical procedures
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:available_in
|
powder form
sponge form
solution form
|
|
gptkbp:care_instructions
|
provided
|
|
gptkbp:clinical_trial
|
conducted
|
|
gptkbp:clinical_use
|
trauma surgery
orthopedic surgery
neurosurgery
plastic surgery
general surgery
cardiovascular surgery
|
|
gptkbp:contraindication
|
hypersensitivity to components
|
|
gptkbp:distribution
|
global
|
|
gptkbp:formulation
|
various formulations
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Codman® Hemostatic Agents
|
|
gptkbp:indication
|
surgical hemostasis
|
|
gptkbp:ingredients
|
gptkb:gel
gptkb:Collage
thrombin
|
|
gptkbp:invention
|
patented
|
|
gptkbp:is_effective_against
|
proven in studies
|
|
gptkbp:manufacturer
|
gptkb:Codman_&_Shurtleff,_Inc.
|
|
gptkbp:manufacturing_process
|
GMP compliant
|
|
gptkbp:marketed_as
|
gptkb:Codman®_brand
|
|
gptkbp:packaging
|
sterile packaging
|
|
gptkbp:patient_population
|
adults
pediatrics
|
|
gptkbp:provides_guidance_on
|
included
|
|
gptkbp:regulatory_compliance
|
required
|
|
gptkbp:research_and_development
|
ongoing
|
|
gptkbp:safety_features
|
established
|
|
gptkbp:shelf_life
|
2 years
|
|
gptkbp:side_effect
|
allergic reaction
monitored
infection risk
local inflammation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:target_market
|
hospitals
clinics
surgical centers
|
|
gptkbp:training
|
for healthcare professionals
|
|
gptkbp:treatment
|
faster recovery
improved hemostasis
lower complication rates
reduced blood loss
|
|
gptkbp:used_for
|
controlling bleeding
|
|
gptkbp:bfsParent
|
gptkb:Codman_Neurosurgery
|
|
gptkbp:bfsLayer
|
7
|